AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Apr 29 2020
Headline Roundup
Experimental Drug Shows Promise as Possible Coronavirus Treatment
Remdisivir, an experimental anti-viral drug, has reportedly generated "positive" data in tests run by the National Institute of Allergy and Infectious Diseases (NIAID) to examine its potential as a COVID-19 coronavirus treatment. Dr. Anthony Fauci and President Donald Trump were among those who celebrated the "good news" Wednesday; the Food and Drug Administration (FDA) is discussing plans
CNBC
Fox News (Online News) 
Yahoo News 
Mar 23 2020
Headline Roundup
Partisan Divide in Coverage of Potential Coronavirus Treatments
Media coverage of the race to find a coronavirus cure has often divided along partisan lines. There are no drugs currently approved to prevent or treat the coronavirus; President Donald Trump recently stated that two specific drugs used in anti-malaria medications — chloroquine and hydroxychloroquine — may eventually provide a base for a coronavirus treatment, which the left and right sides of
BuzzFeed News
Wall Street Journal (News)
Daily Mail
Apr 08 2020
News
Coronavirus Treatments and the Hydroxychloroquine Debate
This Abridge News topic aggregates four unique arguments on different sides of the debate. Here are the quick facts to get you started:
THE QUICK FACTS
Over the last several weeks, President Trump has repeatedly touted experimental drug hydroxychloroquine as a treatment for Covid-19.The president has called the drug a potential “game-changer,” saying: “There’s Abridge News
Nov 14 2020
Analysis
Where Are We in the Quest for Coronavirus Treatments?
The scramble to develop treatments for Covid-19 has paid off. Since the disease first emerged, medical professionals have gone from fumbling in the dark to a better understanding of what drugs work -- notably steroids and the antiviral medicine remdesivir. Most recently, U.S. regulators granted emergency authorization for the use of an antibody therapy made by Eli Lilly.
Bloomberg
Apr 23 2020
Background
COVID-19 Treatment Guidelines
These Treatment Guidelines have been developed to inform clinicians how to care for patients with COVID-19. Because clinical information about the optimal management of COVID-19 is evolving quickly, these Guidelines will be updated frequently as published data and other authoritative information becomes available.
The recommendations in these Guidelines are based on scientific evidence
National Institutes of Health
Oct 22 2020
News
FDA approves antiviral drug remdesivir as coronavirus treatment
The Food and Drug Administration granted approval of remdesivir, an antiviral drug from Gilead Sciences and a treatment for COVID-19.
The drug, sold under the name Veklury, will be used for hospitalized COVID-19 patients, Gilead said. It is the first coronavirus disease treatment to receive FDA approval.
“The approval of Veklury marks an important milestone in efforts to help
Washington Examiner
Oct 05 2020
Analysis
What are the side effects of Trump's coronavirus treatment regimen?
Following President Trump’s coronavirus diagnosis, he has been given an experimental antibody treatment not yet approved for broad use, a course of an antiviral drug shown to help hospitalized coronavirus patients and a steroid typically used for severe COVID-19 cases.
White House physician Sean Conley on Friday afternoon announced Trump was given a single 8-gram dose of biotechnology
The Hill
Jul 17 2020
News
How to Keep Track of All the Potential Coronavirus Treatments
There’s still no cure for the coronavirus, but dozens of drugs and treatments are being tested against it. And you’re not alone if you’ve gotten confused about which ones are mere possibilities and which are widely understood to be useful. The science changes day by day, and sometimes a drug will make headlines based on data that turns out not to be as reliable as it first looked.
This
Lifehacker
Aug 25 2020
News
FDA Approves Plasma Treatments
“The U.S. Food & Drug Administration (FDA) on Sunday said it authorized the use of blood plasma from patients who have recovered from COVID-19 as a treatment for the disease, a day after President Donald Trump blamed the agency for impeding the rollout of coronavirus vaccines and therapeutics for political reasons.” (Reuters)
A study by the Mayo clinic referenced by the FDA noted
The Flip Side
Aug 10 2022
News
Long-COVID treatments: why the world is still waiting
Bhasha Mewar has had it with doctors. Over the past two years, Mewar has spent nearly all of her life savings seeing heart and respiratory specialists, haematologists, urologists, dermatologists and more, in a desperate bid to tame her long-COVID symptoms. She has taken a slew of drugs: beta blockers to calm her racing heart, steroid inhalers to ease her laboured breathing and an antimalarial
Nature.com